0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query mrrpb5 global cancer cdk inhibitors market research report 2018.Your search for "" gave back 1533064 results.
Check point inhibitors are molecules that use the cosmic potential of the immune response system of the body, and its limitless influences to attack...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Cancer Janus Kinase Inhibitors The global Cancer Janus Kinase Inhibitors market was valued at US$ million in 2023 and is anticipated to reach US$...
Catalog:
MRRPB5
March 2024
Price: USD 2,900.00
Immune checkpoints are proteins that play an important role in regulating the immune system. In cancer, the immune checkpoints are activated to...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
Check point inhibitors are molecules that use the cosmic potential of the immune response system of the body, and its limitless influences to attack...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Inhibitor of Nuclear Factor Kappa B Kinase Subunit Beta - Pipeline Review, H2 2019 Summary According to the recently published report 'Inhibitor...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
E3 Ubiquitin Protein Ligase XIAP - Pipeline Review, H2 2019 Summary E3 Ubiquitin Protein Ligase XIAP (Baculoviral IAP Repeat Containing Protein 4 or...
Catalog:
Global Markets Direct
November 2019
Price: USD 3,500.00
Immune checkpoints are proteins that play an important role in regulating the immune system. In cancer, the immune checkpoints are activated to...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Palbociclib is a drug manufactured by Pfizer, marketed under the brand Ibrance, and it is used for the treatment of hormone receptor-positive (HR+ve...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
PARP inhibitors are a group of pharmacological inhibitors of the enzyme poly ADP ribose polymerase (PARP). They are developed for multiple...
Catalog:
MRRPB5
January 2023
Price: USD 4,000.00
Transforming Growth Factor Beta 2 - Pipeline Review, H2 2019 Summary According to the recently published report 'Transforming Growth Factor Beta...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
The IDO (indoleamine 2,3-dioxygenase 1, IDO1, IDO-1, INDO, indoleamine-pyrrole 2,3-dioxygenase) inhibitors pipeline analysis report includes ongoing...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Microtubule inhibitor chemotherapy drugs are a class of anti-tumor chemotherapy drugs, which can inhibit tumor proliferation by inhibiting cell...
Catalog:
MRRPB5
July 2023
Price: USD 2,900.00
PD-1 inhibitors and PD-L1 inhibitors are a group of checkpoint inhibitors being developed for the treatment of cancer. PD-1 and PD-L1 are both...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
There are few available adjuvant/neoadjuvant medicines for treatment of high-risk resectable colorectal cancer. Lack of pipeline agents in this...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Catenin Beta 1 - Pipeline Review, H1 2020 Summary Catenin Beta 1 (Beta Catenin or CTNNB1) pipeline Target constitutes close to 14 molecules. Out of...
Catalog:
Global Markets Direct
May 2020
Price: USD 3,500.00
